It is now well accepted that the p53 C-terminus plays a central role in controlling the activity of the wild-type molecule. In our previous studies, we observed that a Cterminally altered p53 protein (p53AS), generated by an alternative spliced p53 mRNA, induces an attenuated p53-dependent apoptosis, compared to that induced by the regularly spliced form (p53RS). In the present study we analysed the interrelationships between these two physiological variants of wild-type p53, and found that in cells co-expressing both forms, in contrast to the expected additive eect on the induction of apoptosis, p53AS inhibits apoptosis induced by p53RS. This inhibitory eect is speci®c for p53-dependent apoptosis and was not evident in a p53-independent apoptotic pathway induced by growth factor deprivation. Furthermore, the expression of p53AS in transiently transfected cells caused both inhibition of apoptosis and inhibition of the p53RS-dependent transactivation of a number of p53 target genes. These results suggest that expression of an alternatively spliced p53 form may serve as an additional level in controlling the complexity of p53 function by the C-terminal domain. Oncogene (2000) 19, 3395 ± 3403.
Introduction
Wild-type p53 plays a key role in the maintenance of genomic stability (Kastan et al., 1991 Kuerbitz et al., 1992; Lane, 1992; Livingstone et al., 1992; Maltzman and Czyzyk, 1984) . p53 was suggested to be associated with the induction of DNA repair pathways (for review see Ko and Prives, 1996) that could lead to the completion of the cell cycle, or, alternatively, the onset of apoptosis (Clarke et al., 1993; Lowe et al., 1993; Oren, 1994; Yonish-Rouach et al., 1991) and cell dierentiation (Rotter et al., 1994 ; for reviews see Almog and Rotter, 1998; Hall and Lane, 1997) , leading to exit from the cell cycle. Genotoxic stress was shown to stabilize and activate the p53 protein (Kastan et al., 1991; Kuerbitz et al., 1992; Lane, 1992; Livingstone et al., 1992; Lu and Lane, 1993) . It seems that various exogenous or endogenous stimuli, calling for dierent cellular needs, will signal for distinct structural modi®cations occurring at dierent domains of the p53 molecule. A growing body of evidence suggests that post-translational modi®cations of the p53 protein, alternative splicing, and speci®c interactions with distinct cellular proteins, are the major mechanisms responsible for the molecular versatility that enables a single gene to address the multiple functions attributed to the p53 protein (for reviews see Almog and Rotter, 1998; Giaccia and Kastan, 1998; Meek, 1999) .
The C-terminus of p53 protein, which was initially neglected, seems to play an important role in controlling the structure and function of the entire molecule . This domain was shown to exert a negative eect on the DNA sequence-speci®c binding activity mediated by the central core domain of the molecule. A C-terminally deleted p53 molecule (Hupp et al., 1992 (Hupp et al., , 1993 or a p53 molecule with an altered C-terminus generated by alternative splicing (Kulesz-Martin et al., 1994; Wolkowicz et al., 1995) , lost this negative control capacity. Furthermore, the C-terminus of the p53 molecule was shown to interact directly with DNA in a sequencenon-speci®c manner and thus serves as a`sensor' for damaged DNA (Ford and Hanawalt, 1997; Jayaraman and Prives, 1995; Lee et al., 1995; Reed et al., 1995; Wang et al., 1995; Wu et al., 1995) .
The p53 C-terminus was shown to interact with a number of other cellular proteins (Jayaraman et al., 1997 (Jayaraman et al., , 1998 Wang et al., 1995 Wang et al., , 1996 Waterman et al., 1998) that may modify the activity of the protein. Synthetic peptides corresponding to the p53 C-terminus were shown to restore the wild-type biological functions of a variety of mutant p53 proteins (Muller-Tiemann et al., 1998; Selivanova et al., 1997) . Furthermore, p53 protein stabilization was also shown to be controlled by the C-terminus. The integrity of the C-terminus is critical for p53 protein to participate in the mdm-2 degradation pathway. Although mdm-2 binds p53 through the N-terminus, it was observed that deletion of p53 C-terminus rendered the protein resistant for degradation in this pathway (Kubbutat et al., 1998) .
The p53 C-terminus can be modi®ed by several posttranslational modi®cations. Phosphorylations and dephosphorylations in this site were shown to modulate p53 functions (Steegenga et al., 1996; Waterman et al., 1998) . Acetylation of the p53 C-terminus by the p53 coactivators, p300 and PCAF, activates the p53 sequence speci®c DNA binding (Gu and Roeder, 1997; Sakaguchi et al., 1998) . O-glycosylation of the p53 C-terminus in colon carcinoma derived cell line, EB-1, also correlated with the DNA binding activity of p53 (Shaw et al., 1996) . Furthermore, interactions of p53 with single strands of DNA cause the protein to undergo proteolytic cleavage in the C-terminal domain (Okorokov et al., 1997) . These post-translational modi®cations in the p53 protein might serve as a mechanism for keeping a cellular pool of p53 protein at a latent conformation, which could be activated instantly when required.
The fact that a C-terminally altered p53 protein, encoded by alternative spliced p53 mRNA, is expressed in normal cells (Arai et al., 1986; Han and KuleszMartin, 1992; Kulesz-Martin et al., 1994; Wolf et al., 1985) , further supports the notion that structural exibility of this domain is important in controlling p53 activity. In murine cells this altered p53 mRNA (Arai et al., 1986) , that consists of 25 ± 33% of p53 mRNA (Han and Kulesz-Martin, 1992; Will et al., 1995) , codes for a p53 protein in which the 26 most extreme C-terminally amino acids of p53 are replaced by 17 new amino acids (Arai et al., 1986) . Comparison of alternative spliced p53 protein (p53AS) and regular spliced p53 (p53RS) indicated that the two forms can be dierentially expressed during the cell cycle (KuleszMartin et al., 1994) , and may be associated with various biological activities. It was found that only p53AS binds eciently to the p53 response oligonucleotide (Wolkowicz et al., 1995; Wolkowicz and Rotter, 1997) . Interestingly, complex formation between the two yields a product that does not bind spontaneously to p53 responsive DNA sequence (Wolkowicz et al., 1995) .
p53AS is mostly expressed in the G 2 phase of the cell cycle, and is preferentially expressed in proliferating cells, not in dierentiating cells (Kulesz-Martin et al., 1994) . In normal epidermis, it was shown that while p53RS is predominantly expressed in the less mature cells, the p53AS form is preferentially expressed in the more mature cells (Rehberger et al., 1997) . It was also reported that only p53RS, and not p53AS, has the ability to promote re-annealing of single strand RNA or DNA (Wu et al., 1995) . Interestingly, these two wild-type p53 protein forms were shown to dier in their response to DNA damage. In epidermal tumor cells, the kinetics of nuclear accumulation and eciencies of binding to the p53 consensus sequence of p53RS and p53AS are dierent (Wu et al., 1997) . It is worth noting that expression of protein isoforms generated by alternative splicing is common in the recently described family of the p53 homologues. Most signi®cant is the observation that p63 splice variants seem to control the activity of another (Yang et al., 1998) .
The involvement of wild-type p53 in the induction of apoptosis is unequivocally accepted (Gottlieb and Oren, 1996) . Recent studies indicate that the p53 Cterminus also regulates the p53-dependent apoptotic process (Haupt et al., 1995; Wang et al., 1996) . When we compared apoptotic patterns mediated by either wild-type p53 molecules or a C-terminally altered p53 we observed that cell lines which express the p53AS form exhibited an attenuated rate of apoptosis when compared to cells expressing the regular spliced p53 form under the same experimental conditions. Alternation of the p53 C-terminus caused a delay in the induction of apoptosis, thus suggesting that the Cterminal amino acids of p53 control the rate of the apoptotic pathway .
The observations that two wild-type p53 protein forms, which dier in their C-terminus and exhibit variations in their biological activities, are co-expressed in normal cells, prompted us to examine the physiological signi®cance of the interrelationships between these two species. The elucidation of a possible functional link between p53RS and p53AS is expected to reveal the mechanisms by which the Cterminus of p53 regulates wild-type p53 activities. To that end, we co-expressed the two p53 protein forms, both in stable clones as well as in transiently transfected cells, and followed the apoptotic patterns of the co-expressing cells. Our study demonstrates that while each wild-type p53 protein form can by itself induce apoptosis, although at dierent rates, the coexpression of these two p53 protein forms results in an inhibition of the apoptosis induced by p53RS. Similarly, the co-expression of p53AS together with p53RS caused an inhibition in the transcriptional activity of p53RS. This suggests that the ratio of p53RS and p53AS, expressed at dierent physiological conditions, may be an important determinant in the regulation of p53-dependent apoptosis.
Results

Establishment and characterization of RS/AS-ts-co-expressor M1/2 derived clones
Previously, we established a battery of individual cell lines derived of the M1/2 p53 non-producer parental cell line, which express either the p53RS or p53AS protein forms. We found that individual M1/2 derived clones, which express similar levels of either p53AS or p53RS temperature sensitive (ts) mutants, exhibited dierent kinetics in the induction of apoptosis following expression of wild-type p53 conformation. Cells expressing the p53AS protein reached apoptotic levels similar to those exhibited by p53RS clones, at a Figure 1 Analysis of p53 protein expression in M1/2 derived clones. Western blot analysis of M1/2 cells expressing dierent levels of p53AS-ts or p53RS-ts. Clone PLXSN was infected with an empty virus, and serves as a negative control. Clones p53RS-ts-53 and 63 express only the p53RS-ts protein. Clones p53RS/ AS-ts-7, 5, and 2 co-express p53RS-ts with dierent levels of p53AS-ts. Clones p53AS-ts-27 and 41 express only the p53AS-ts protein. p53 protein forms were detected by the polyclonal antibody anti-AS, the monoclonal antibodies PAb-240, and PAb-421. The anti-tubulin monoclonal antibody was used as a control
The role of the p53 C-terminus in apoptosis N Almog et al delay of about 12 h. Furthermore, analysis of the expression of p53 downstream genes in cells expressing p53AS, indicated a delayed expression which corresponded to the rate of apoptosis observed in these cells . The delay in apoptosis may be a result of the induction by p53AS of the same pathways as p53RS, but at a less ecient and slower manner. Alternatively, p53AS may also induce negative regulators which actively inhibit this process.
To address this issue we established clones which express the two wild-type p53 protein forms concomitantly. If the two forms of p53 act in the same pathway, and utilize the same machinery, then coexpression of the two forms is expected to facilitate apoptosis in correlation with the total amount of p53 expressed in cells. However, if p53AS induces apoptosis negative regulators, then reduction in apoptosis will be observed. For that purpose the M1/2 derived clone, p53RS-ts-53, which already expresses p53RS , was infected with a retrovirus expressing the temperature-sensitive mutant of p53AS-ts. A series of cell lines carrying a constant amount of p53RS protein, with increasing amounts of p53AS, was generated.
Comparison of the various p53 protein levels in the dierent clones is depicted in Figure 1 AS-ts-2, 5 and 7, which express both p53 forms, were compared with clones p53AS-ts-41 and 27, which express only p53AS, clone p53RS-ts-63, which expresses high levels of p53RS, and the parental line p53RS-ts-53. Clone PLXSN, which was infected with an empty virus served as a control. Western blot analysis, using various speci®c antibodies which recognize dierent epitopes of the p53 protein, was performed. The anti-AS polyclonal antibody speci®cally recognized the p53AS C-terminus. As expected, clones p53RS/AS-ts-2, 5 and 7 and clones p53AS/ts-41 and 27 expressed dierent levels of p53AS. It should be noted that clone p53RS/AS-ts-7 expressed relatively low levels of p53AS which were observed only following longer exposures. The monoclonal antibody PAb-240 that recognizes a shared epitope (Gannon et al., 1990) detected both p53AS and p53RS. Monoclonal antibody PAb-421 (Harlow et al., 1981) , which recognizes the p53RS C-terminus, detected the protein only in the p53RS-ts-53-derived clones as well as in clone p53RS-ts-63. The levels of p53RS protein seen were equal in all p53RS-ts-53-derived clones and were not modi®ed following infection with the p53AS expressing recombinant virus.
p53AS regulates the level of p53-induced apoptosis
We next analysed the apoptotic patterns of the various co-expressor clones. Analysis of the apoptotic level was performed using Annexin V assay of the various clones following shift to 328C (Figure 2A,B) . Annexin V is a phospholipid binding protein that has a high anity for the phospholipid phosphatidylserine (PS). In apoptotic cells, the PS is translocated from the inner to the outer lea¯et of the plasma membrane, thereby exposing PS to the external surface of the cell. This externalization of PS occurs in the earliest stages of apoptosis (Vermes et al., 1995) .
Apoptotic patterns of the various clones, following a shift to 328C, estimated by the Annexin V assay, are presented in Figure 2 . Staining patterns of the cells both with Propidium Iodine (evaluation of cell survival) and Fluorescein labelled Annexin-V (early apoptotic cells), indicate that more than 50% of cells of clone p53RS-ts-53 exhibited apoptotic features, by 48 h, following the shift to 328C (compare Figure 2A and B panel (c)). In agreement with our previous observation , apoptosis in clone p53AS-ts-27 was signi®cantly reduced when compared to that in clone p53RS-ts-53 under the same experimental conditions (7% versus 56% of apoptotic cells, respectively) ( Figure 2C ). Superimposed expression of p53AS in cells which already express p53RS, such as clones p53RS/AS-ts-7, 5 and 2, resulted in reduced apoptosis compared to the parental clone p53RS-ts-53. It should be noted that the suppressive activity exerted by p53AS correlates with the amount of p53AS expressed in the individual clone ( Figure 2C ). However, this correlation is not quantitatively linear.
Similar apoptotic patterns were observed when analysed by DNA ladder assay. M1/2 derived clones were grown at 328C for 24 h, and then collected and analysed on an agarose gel ( Figure 2D ). In agreement with our previous observations , clones p53RS-ts-61 and 63, which express the highest levels of p53RS, have the most intense degradation of DNA. Under the same experimental conditions, barely any apoptosis was observed in clones which express p53AS only (clones p53AS-ts-41, 28 and 27). Apoptosis in the co-expressor clones p53RS/AS-ts-2, 7 and 5 was reduced compared to that of the parental p53RS producer clone. No fragmentation of genomic DNA was evident in clone PLXSN, which was infected with an empty virus.
Analysis of apoptosis along a broader time scale further con®rmed that apoptosis in clone p53RS/AS-ts-5, co-expressing the two p53 protein forms, was consistently lower than that observed in the parental p53RS-ts-53 clone ( Figure 2E ). Again, under the same conditions, the kinetics of apoptosis induction in the clone which expresses p53AS only (clone p53AS-ts-27), was signi®cantly slower compared to that in the clone which expresses only p53RS. These results further support the conclusion that addition of p53AS to clone p53RS-ts-53 results in an inhibition of the apoptosis, whereas increase in p53RS levels, results in an enhanced apoptosis. This suggests that the ®nal outcome of the apoptotic level may be determined by the relative amount of p53AS and p53RS co-expressed in the cell.
Inhibition of p53RS-induced apoptosis in transiently transfected cells
In order to further con®rm the results above, obtained in stable M1/2-derived clones, we transiently transfected p53-null human lung carcinoma H1299 cells with the p53 splice variants coding constructs, and compared the level of apoptosis which was induced by each of the p53 protein forms and by dierent ratios of co-transfected p53RS and p53AS ( Figure 3 ). As expected, transfection of equal amounts of either p53RS or p53AS coding plasmids resulted in a higher Although each of the forms can induce apoptosis by itself, the addition of increasing amounts of p53AS to a constant amount of p53RS resulted in a proportional inhibition of the p53RS induced apoptosis (Figure 3 , compare lane 2 with lanes 5 and 6). This inhibitory eect does not appear to be due to saturation of wildtype p53 protein in the cells. Indeed, increase in the level of p53RS protein resulted in an enhanced p53-dependent apoptosis (Figure 3, lane 7) . Thus, in agreement with the above described observations in the stable M1/2 clones, elevation of p53RS protein level results in the augmentation of the apoptosis process, while addition of p53AS protein results in the attenuation of the p53RS-induced apoptosis.
p53AS does not inhibit p53-independent apoptosis
To assess whether the observed inhibition of apoptosis is indeed a result of an interplay between p53AS and p53RS protein forms, or whether p53AS will also aect p53-independent apoptosis, we have analysed the eect of p53AS expression on a p53-independent apoptotic pathway. The M1/2 parental cell line was selected as a clone that is dependent for its growth on the presence of condition medium (CM) (Peled et al., 1996a) . Withdrawal of the CM will induce a p53-independent apoptosis, while induction of wild-type p53 expression, following temperature shift, will turn on the p53-dependent apoptotic pathway (Peled et al., 1996b ). Previously we found that p53-dependent apoptosis is an immediate response, whereas the p53-independent pathway, induced following growth factor deprivation, is slower. In the M1/2 cells, p53RS-dependent apoptosis pathway, which is induced by wild-type p53 expression, cooperated with p53-independent apoptosis pathway, which is induced by CM withdrawal, resulting in augmented apoptosis (Peled et al., 1996b) . To determine whether the inhibtion of p53RS-induced apoptosis by p53AS is speci®c for the p53-dependent pathway, we analysed the eect of p53AS expression on p53-independent apoptosis, induced by CM deprivation. To that end, we compared the survival of M1/2 derived clones which express p53RS (clone p53RS-ts-53), p53AS (p53AS-ts-27) or the empty virus (PLXSN). The cells were grown for 72 h at 378C with or without conditioning medium. As depicted in Figure 4A , whereas only p53-independent apoptosis is induced following CM deprivation in the empty clone, PLXSN, both clones p53RS-ts-53 and p53AS-ts-27 exhibited augmented level of apoptosis, when p53-independent apoptosis (CM depravation) and p53-dependent apoptosis (temperature shift) were induced simultaneously. In all cells incubated at 328C, the total level of apoptosis was increased when the clones were grown in the absence of CM, compared to that in the presence of CM.
It should be mentioned that the addition of p53AS expression to the clone p53RS-ts-53, which was achieved by the infection of this clone by a retrovirus carrying the resistance gene (see Materials and methods), did not inhibit p53-independent apoptosis, clearly indicating that there are no negative eects which are exerted by mere retroviral infection. Therefore, the observed attenuation in p53-dependent apoptosis is speci®c for p53AS expression.
These results were further con®rmed when the kinetics of concomitant induction of p53-dependent and p53-independent apoptosis in the various clones was compared along a broader time scale ( Figure 4B ). Following CM deprivation and incubation at 328C, apoptosis in clone p53RS-ts-53 was the most prominent. In clone p53RS/AS-ts-5, in which p53AS was coexpressed together with p53RS, an attenuated induction of apoptosis resulted from the inhibitory eect of p53AS on p53RS-induced apoptosis. In agreement with The role of the p53 C-terminus in apoptosis N Almog et al the previous results, the level of apoptosis in this clone is higher than the level in clones which express p53AS only. It can be concluded, therefore, that like p53RS, the wild-type p53AS protein form also does not inhibit p53-independent apoptosis, but rather co-operates to yield a higher level of apoptosis. Thus, p53AS inhibits only apoptosis induced by p53RS, and does not aect other p53-independent pathways.
p53AS regulates p53RS-induced transcriptional activity
In an attempt to de®ne the molecular mechanisms which underlie the apoptosis-inhibitory eect mediated by p53AS, we analysed the transcriptional activity of p53RS and p53AS. Although the transactivation domain of the p53 protein is localized at the N' terminus, there are certain indications that modi®ca-tions of the C' terminus can impair the transcription activity of the protein (Haupt et al., 1995; Zhou et al., 1999) . In order to compare the transcriptional activity of p53RS and p53AS, and to determine whether p53AS interferes with p53RS activity, we transiently co-transfected p53/mdm-2 null 174.2 cell line (McMasters et al., 1996) , with several constructs which contain the luciferase gene under dierent p53-dependent promoters together with p53RS or p53AS coding plasmids.
As can be seen in Figure 5 , p53RS is a more potent transactivator of the p53-dependent promoters analysed than p53AS. Although each of the p53 protein forms can induce the transcription from these promoters, in all promoters analysed, addition of p53AS reduced the p53RS-dependent transactivation. This is in contrast to the usual pattern of an additive eect, mostly evident with the bax promoter, where increasing the amount of p53RS resulted in an increase of the transcriptional activity. It can be clearly seen that although the total amount of p53 was constant in the cells transfected with p53RS+p53AS or with p53RS+p53RS, a signi®cant reduction in the luciferase transcription was evident only when the p53AS was coexpressed. It should be noted that the observation that the co-expression of p53RS and p53AS caused an inhibition of the transcription from the apoptosispromoting gene Bax, correlates with the inhibition of apoptosis observed above.
Discussion
Apoptosis is a complex process that was shown to be controlled by positive and negative regulators. Genes coding for apoptosis inducers and those coding for apoptosis inhibitors have been identi®ed. For example, Bax promotes apoptosis, while bcl-2, can counter some stimuli of cell death (Oltvai and Korsmeyer, 1994; Symonds et al., 1994; Williams, 1991; Wyllie, 1995) . So far, it is believed that wild-type p53 functions as a positive inducer of apoptosis (Clarke et al., 1993; Lowe et al., 1993; Yonish-Rouach et al., 1991 . Indeed, apoptotic levels were found to correlate directly with the amounts of p53 protein expressed (Peled et al., 1996b) . All functional domains of p53 seem to contribute to this activity. Deletions of either the Nterminus (Haupt et al., 1995; Rowan et al., 1996) or the C-terminus were found to hamper the onset of p53-dependent apoptosis (Haupt et al., 1995; Zhou et al., 1999) .
Previously, we found that alteration of the p53 Cterminus seems to generate a molecule with a reduced capacity to induce apoptosis. Cells which express the p53AS protein exhibited an attenuated apoptotic rate when compared to cells which express the same protein level of p53RS . The observation that both deletion of the C-terminus (Haupt et al., 1995; Zhou et al., 1999) as well as acquisition of an altered C-terminus lead to a reduction in apoptosis, raises the question of whether the two are operated through the same mechanism.
Our present study suggests that although the p53AS is capable of inducing apoptosis, it also actively interferes and inhibits the apoptosis induced by p53RS. We found in two independent experimental systems that while an increase in p53RS protein levels results in the enhancement of apoptosis induction, coexpression of increasing levels of p53AS protein results in the inhibition of p53RS-induced apoptosis. Furthermore, p53AS speci®cally inhibits the p53-dependent pathway for induction of apoptosis, but does not aect the p53-independent ones.
Several mechanisms may explain such a scenario. It could be that p53AS, a physiological variant of the p53 protein, has unique transactivation properties, capable of inducing genes that may interfere speci®cally with the p53-dependent induction of apoptosis. Although the p53AS diers from the p53RS in the spontaneous DNA binding activity (Wolkowicz et al., 1995) , both are capable of transactivating the known p53-target genes, such as waf-1, bax and Cyclin G. This is in agreement with previous studies showing that dierent C-terminally deleted p53 proteins are transcriptionally Figure 5 p53RS and p53AS transcriptional activity in transiently transfected 174.2 cells. Cells were co-transfected with dierent combinations of p53RS or p53AS coding plasmids (1 ng each) together with 1 mg of either Waf-1-luciferase (A), Baxluciferase (B), or Cyclin G-luciferase (C), as indicated. The luciferase activity was measured 24 h post-transfection, and was calculated according to the transfection eciency in each transfection experiment as measured by b-gal activity. Each assay was done in triplicate
The role of the p53 C-terminus in apoptosis N Almog et al active (Haupt et al., 1995; Wu et al., 1997) , and with the observation that p53RS and p53AS have the same DNA binding speci®cities . It is notable, however, that the eciency of transcription activity of the p53AS is lower than that of p53RS, which may explain the attenuated apoptosis induced by p53AS. Alternatively, by forming hetero-complexes with p53RS, p53AS might alter the latter biological functions, or compete with p53RS for certain essential factors in induction of apoptosis. In our present study, we found that under these experimental conditions, p53RS and p53AS are physically associated (data not shown). These interactions may generate hetero-complexes with dierent anities for p53 consensus DNA sequence, which may determine the net biological eects mediated by p53 in the cell. It is tempting to speculate that the heterogeneity of the p53 protein population may serve as a molecular mechanism which regulates the in vivo wild-type p53 activity. Indeed, coexpression of p53AS with p53RS resulted in the inhibition of p53-induced transactivation, while elevation of the p53RS protein level caused an enhancement of the reporter gene expression. The fact that a certain correlation between the amount of the added p53AS protein level and the level of inhibition of transactivation and of apoptosis-inhibition exists, suggests that the ratio between the p53RS and p53AS protein levels might dictate the ®nal outcome of the p53 protein activity. Therefore, the data observed in this study suggest that the C-terminus of p53 is an important determinant which regulates at least some of the p53 biological functions, and that alternative splicing of p53 mRNA, which generates an altered p53 protein with a unique C-terminus, controls the levels of p53-induced apoptosis.
Alternative splicing is a molecular mechanism known to enlarge the variety of biological responses from one gene. In this way, for example, activators and repressors can be encoded from the same transcription factor gene (for a review see Foulkes and SassoneCorsi, 1992) . These activators and repressors can be consistently co-expressed in vivo, where the ratio of the dierent forms can be modulated in a temporal and tissue speci®c fashion. It appears that such a mechanism also exists for the p53 gene. Indeed, the ratio between p53RS and p53AS proteins vary in dierent organs in vivo, along the cell cycle, and the cell dierentiation phase (Kulesz-Martin et al., 1994; Rehberger et al., 1997; Will et al., 1995) . This further indicates that these protein variants may possess unique biological activities that induce p53-dependent apoptosis by dierent manners.
Although a human alternatively spliced variant of p53 was found in lymphocytes (Flaman et al., 1996) , other post translational modi®cations that are known to occur at the C-terminus of the human p53 protein, might further confer to the biological activities repertoire. Generation of alternative pathways can also be mediated by cellular homologues. However, in the case of p53, although several such candidates were suggested (Jost et al., 1997; Kaghad et al., 1997; Schmale and Bamberger, 1997) , none of them seemed to serve as an ideal p53 analogue. Interestingly, in these newly discovered`homologues' of the p53 protein, alternative splicing of mRNA is frequently observed. Several isoforms of p73 dier at their Cterminus as a result of alternative splicing of p73 mRNA (Jost et al., 1997; Kaghad et al., 1997) . Interestingly, these variants dier markedly in their ability to transactivate downstream genes and to aect cell growth (De Laurenzi et al., 1998) . The rat KET gene, and the suggested human and murine homologues, p63, p40 and p51, also encode for several alternatively spliced mRNA (Osada et al., 1998; Schmale and Bamberger, 1997; Trink et al., 1998; Yang et al., 1998) . It should be noted that several of these splice variants were shown to inhibit p63 and p53 transcriptional activity (Yang et al., 1998) . The relevance of the homology of the protein structure to the molecular function still remains to be determined, but the existence of splicing variants in all of the p53 homologues, together with the notion that p63 splice variants can act in a dominant negative manner, further strengthen the evolutionary and physiological importance of the p53 C' terminus, and emphasize the role of the alternatively spliced p53 form in the regulation of p53 activities.
Materials and methods
Cell lines and culture medium
The M1/2-derived clones were established and characterized previously . The M1/2 derived clones were grown continuously in the presence of 10% conditioned medium (CM), which was obtained from 14F.1 cells (Peled et al., 1996a) . H1299 carcinoma cells, derived from human nonsmall cell lung cancer, are p53-null cells (ATCC number: CRL-5803). These cells are maintained in RPMI 1640 medium with 10% foetal calf serum. 174.2 cells were kindly provided by G Lozano. These cells are p53/mdm-2 null cells, and were maintained in DMEM medium with 10% foetal calf serum (McMasters et al., 1996) .
Plasmids and cell infections
The gene coding for the ts mutant of p53AS was derived from PLXSNp53 ASval135. An EcoRI fragment containing the coding sequence was transferred into pBabe plasmid, which contained the puromycin resistance gene (Morgenstern and Land, 1990) . This resulted in the generation of the pBabe-Puro-p53ASval135 plasmid. This plasmid was transfected into virus producing cells, which were then cocultivated with the M1/2 derived clone p53RS-ts-53. Drugresistance single cell clones were isolated by limiting dilution. For luciferase assays, the reporter plasmids, containing the luciferase gene under the control of p53-target promoter, were kindly provided by M Oren.
Transfections and luciferase assays H1299 cells were transfected by the calcium phosphate method. The DNA precipitates were left on the cells for 5 h, and then the cells were shaken with medium containing 10% glycerol for 5 min. The pCMV-empty plasmid was used to maintain a constant amount of transfected DNA in each sample. The luciferase assays were done in the p53/mdm-2 null cell line 174.2. These cells were transfected in 24-well plates using the Lipofectamine kit (Life Technologies, Inc.). The pCMV-empty plasmid was used to maintain a constant amount of transfected DNA in each sample. Twenty-four hours post transfection the cells were washed with PBS and lysed in the wells with cell lysis buer (Promega) and incubated for 10 min at room temperature. The luciferase
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The role of the p53 C-terminus in apoptosis N Almog et al activity in the lysate was quantitated in the presence of luciferin (Promega) and ATP, using the Lucy 3 luminometer microplate system (rosys anthos). Transfection eciency was determined according to b-gal activity derived from a constant amount of transfected b-gal expression plasmid. The results are presented as the ratio of the luciferase activity and the b-gal activity of each sample. Each transfection was performed in triplicates, and each experiment was repeated several times.
Western blot
0.5610 6 cells were collected, lysed in sample buer (140 mM Tris (pH 6.8), 22.4% glycerol, 6% SDS, 10% b-mercaptoethanol, 0.02% bromophenol blue) and subjected to SDSpolyacrylamide gel electrophoresis. The proteins were detected using the Protoblot Western blot Ap system (Promega). The nitrocellulose membranes were blocked with 5% dry skim milk in TBST (10 mM Tris-HCl pH 8.0, 150 mM NaCl, 0.05% Tween 20) for 30 min. Incubation with the ®rst antibody for 30 min was followed with three washes with TBST, and incubation with a second antibody conjugated to HRP enzyme for 30 min. The staining was observed using the enhanced chemiluminescence protocol (Amersham). The antibodies that were used were previously described .
Cell viability assay
Apoptosis of M1/2-derived clones was assayed by Annexin staining. 10 6 cells were collected, washed with PBS, and suspended in a labelling solution containing propidium iodide (PI) and¯uorescein-labelled Annexin-V (Annexin-V-FLUOS) (Boehringer Mannheim). Viability was assayed in the FACS (FACSort¯ow cytometry (Becton Dickinson) with Cell Quest software) and was statistically calculated according to the percentage of cells which were positively stained for Annexin-V and for PI. Apoptosis of H1299 transiently transfected cells was analysed by PI staining. The cells were transfected with a constant amount of total DNA which includes the p53 coding plasmids together with a GFP coding plasmid and an empty pCMV plasmid. The cells were collected 48 h post transfection and washed in cold PBS. Cells were ®xed in 70% methanol in HBSS and incubated overnight at 7208C. Cells were washed twice in PBS and incubated with 50 mg/ml RNase A and 25 mg/ml PI. Samples were then analysed in a cell sorter (FACSort, Becton Dickinson). Highly GFP expressing cells were gated and thus the cell cycle pattern of only the highly GFP-positive cells fraction was analysed according to their PI staining. Apoptotic cells were statistically calculated according to the percentage of the sub-G1 fraction.
